Literature DB >> 20146008

Psychometric properties of the EQ-5D in a study of people with mild to moderate dementia.

Simone Kunz1.   

Abstract

PURPOSE: Due to their cognitive impairment, the health-related quality of life (HRQoL) of patients with dementia is often rated by proxies. This study aims to analyse the psychometric properties of the EQ-5D applied to patients with mild to moderate dementia and their family caregivers.
METHODS: Three hundred and ninety patients and their caregivers were asked to assess the patients' HRQoL using the EQ-5D. The German population-based time trade-off values were used to calculate utility weights. Acceptance, discriminative ability, construct validity, inter-rater agreement and responsiveness were tested. Factors that could have an impact on inter-rater agreement were analysed using a multivariate regression.
RESULTS: Five per cent of patients did not fill out the EQ-5D. The response rate of caregivers and of patients with mild dementia was higher than that of patients with moderate dementia. There were no floor or ceiling effects. The test results of the caregivers concerning construct validity and responsiveness were better than those of the patients. The inter-rater reliability was not satisfactory either on the dimension level or on the utility score level. Caregivers gave the patients' HRQoL significantly lower ratings than did the patients themselves. Better abilities of the patient to perform activities of daily living and a lower subjective burden of the caregiver were associated with a higher inter-rater agreement.
CONCLUSIONS: The study showed that the EQ-5D is especially applicable to patients with mild dementia and their caregivers as proxies. However, there are important differences between patient and proxy ratings, even in cases of mild dementia, at the dimension level as well as utility score level, which should be considered in the interpretation of quality of life scores.

Entities:  

Mesh:

Year:  2010        PMID: 20146008     DOI: 10.1007/s11136-010-9600-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  38 in total

Review 1.  Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.

Authors:  A Clegg; J Bryant; T Nicholson; L McIntyre; S De Broe; K Gerard; N Waugh
Journal:  Health Technol Assess       Date:  2001       Impact factor: 4.014

2.  [The Barthel Index in geriatrics. A context analysis for the Hamburg Classification Manual].

Authors:  Norbert Lübke; Matthias Meinck; Wolfgang Von Renteln-Kruse
Journal:  Z Gerontol Geriatr       Date:  2004-08       Impact factor: 1.281

3.  Utility-based Quality of Life measures in Alzheimer's disease.

Authors:  Gary Naglie; George Tomlinson; Catherine Tansey; Jane Irvine; Paul Ritvo; Sandra E Black; Morris Freedman; Michel Silberfeld; Murray Krahn
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

4.  [Cost-effectiveness of galantamine in a german context].

Authors:  Michael Happich; Bernd Schweikert; Axel Mühlbacher
Journal:  Psychiatr Prax       Date:  2005-04

5.  Different evaluations of the health related quality of life in dialysis patients.

Authors:  Pablo Rebollo; Fernando Alvarez-Ude; Covadonga Valdés; Carmen Estébanez
Journal:  J Nephrol       Date:  2004 Nov-Dec       Impact factor: 3.902

6.  Validation of the NOSGER (Nurses' Observation Scale for Geriatric Patients): reliability and validity of a caregiver rating instrument.

Authors:  M Wahle; S Häller; R Spiegel
Journal:  Int Psychogeriatr       Date:  1996       Impact factor: 3.878

7.  Quality of life in cancer patients--an hypothesis.

Authors:  K C Calman
Journal:  J Med Ethics       Date:  1984-09       Impact factor: 2.903

8.  [IDA project--concept and implementation of a cluster-randomized trial on dementia management in a general practice setting].

Authors:  Jörg Lauterberg; Maria Grossfeld-Schmitz; Stephan Ruckdäschel; Simone Neubauer; Hilmar Mehlig; Maren Gaudig; Dieter Hruschka; Horst Christian Vollmar; Rolf Holle; Elmar Grässel
Journal:  Z Arztl Fortbild Qualitatssich       Date:  2007

9.  What explains differences between dementia patients' and their caregivers' ratings of patients' quality of life?

Authors:  Laura P Sands; Patricia Ferreira; Anita L Stewart; Meryl Brod; Kristine Yaffe
Journal:  Am J Geriatr Psychiatry       Date:  2004 May-Jun       Impact factor: 4.105

10.  Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments.

Authors:  Claire A G Wolfs; Carmen D Dirksen; Alfons Kessels; Daniëlle C M Willems; Frans R J Verhey; Johan L Severens
Journal:  Health Qual Life Outcomes       Date:  2007-06-14       Impact factor: 3.186

View more
  29 in total

Review 1.  Can The EQ-5D Detect Meaningful Change? A Systematic Review.

Authors:  Nalin Payakachat; Mir M Ali; J Mick Tilford
Journal:  Pharmacoeconomics       Date:  2015-11       Impact factor: 4.981

2.  Use of the Tailored Activities Program to reduce neuropsychiatric behaviors in dementia: an Australian protocol for a randomized trial to evaluate its effectiveness.

Authors:  C M O'Connor; L Clemson; H Brodaty; Y H Jeon; E Mioshi; L N Gitlin
Journal:  Int Psychogeriatr       Date:  2014-02-10       Impact factor: 3.878

Review 3.  Health state values for use in the economic evaluation of treatments for Alzheimer's disease.

Authors:  James Shearer; Colin Green; Craig W Ritchie; John P Zajicek
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

4.  How does the EQ-5D perform when measuring quality of life in dementia against two other dementia-specific outcome measures?

Authors:  Elisa Aguirre; Sujin Kang; Zoe Hoare; Rhiannon Tudor Edwards; Martin Orrell
Journal:  Qual Life Res       Date:  2015-07-11       Impact factor: 4.147

Review 5.  Measurement properties of the EQ-5D in populations with a mean age of ≥ 75 years: a systematic review.

Authors:  Sophie Gottschalk; Hans-Helmut König; Mona Nejad; Judith Dams
Journal:  Qual Life Res       Date:  2022-08-01       Impact factor: 3.440

6.  Psychological Resilience Among Older Japanese Adults With Mild Cognitive Impairment During the COVID-19 Pandemic.

Authors:  Nanae Matsumoto; Taiki Sugimoto; Yujiro Kuroda; Kazuaki Uchida; Yoshinobu Kishino; Hidenori Arai; Takashi Sakurai
Journal:  Front Psychiatry       Date:  2022-06-10       Impact factor: 5.435

7.  Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.

Authors:  Rahul Khanna; Krutika Jariwala; John P Bentley
Journal:  Qual Life Res       Date:  2013-04-25       Impact factor: 4.147

8.  Challenges with cost-utility analyses of behavioural interventions among older adults at risk for dementia.

Authors:  Jennifer C Davis; Stirling Bryan; Carlo A Marra; Ging-Yuek R Hsiung; Teresa Liu-Ambrose
Journal:  Br J Sports Med       Date:  2013-11-06       Impact factor: 13.800

9.  Health-related quality of life in people with advanced dementia: a comparison of EQ-5D-5L and QUALID instruments.

Authors:  Elizaveta Sopina; Lynn Chenoweth; Tim Luckett; Meera Agar; Georgina M Luscombe; Patricia M Davidson; Constance D Pond; Jane Phillips; Stephen Goodall
Journal:  Qual Life Res       Date:  2018-09-05       Impact factor: 4.147

10.  FIRE (Facilitating Implementation of Research Evidence): a study protocol.

Authors:  Kate Seers; Karen Cox; Nicola J Crichton; Rhiannon Tudor Edwards; Ann Catrine Eldh; Carole A Estabrooks; Gill Harvey; Claire Hawkes; Alison Kitson; Pat Linck; Geraldine McCarthy; Brendan McCormack; Carole Mockford; Jo Rycroft-Malone; Angie Titchen; Lars Wallin
Journal:  Implement Sci       Date:  2012-03-27       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.